A detailed history of New York State Common Retirement Fund transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, New York State Common Retirement Fund holds 76,228 shares of ALNY stock, worth $18.5 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
76,228
Previous 94,685 19.49%
Holding current value
$18.5 Million
Previous $23 Million 8.88%
% of portfolio
0.03%
Previous 0.03%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

SELL
$233.81 - $287.01 $4.32 Million - $5.3 Million
-18,457 Reduced 19.49%
76,228 $21 Million
Q2 2024

Jul 31, 2024

BUY
$143.31 - $247.0 $131,701 - $226,993
919 Added 0.98%
94,685 $23 Million
Q1 2024

May 07, 2024

SELL
$146.51 - $198.2 $2.66 Million - $3.6 Million
-18,148 Reduced 16.22%
93,766 $14 Million
Q4 2023

Feb 01, 2024

SELL
$151.41 - $196.57 $1.98 Million - $2.57 Million
-13,049 Reduced 10.44%
111,914 $21.4 Million
Q3 2023

Nov 07, 2023

SELL
$170.77 - $211.65 $2.93 Million - $3.63 Million
-17,156 Reduced 12.07%
124,963 $22.1 Million
Q2 2023

Aug 07, 2023

SELL
$185.01 - $212.05 $1.1 Million - $1.27 Million
-5,969 Reduced 4.03%
142,119 $27 Million
Q1 2023

May 18, 2023

BUY
$182.66 - $235.53 $73,064 - $94,212
400 Added 0.27%
148,088 $29.7 Million
Q1 2023

May 02, 2023

SELL
$182.66 - $235.53 $1.28 Million - $1.65 Million
-7,010 Reduced 4.53%
147,688 $29.6 Million
Q4 2022

Jan 30, 2023

BUY
$185.53 - $241.31 $1.24 Million - $1.61 Million
6,680 Added 4.51%
154,698 $36.8 Million
Q3 2022

Nov 08, 2022

SELL
$138.54 - $232.0 $707,385 - $1.18 Million
-5,106 Reduced 3.33%
148,018 $29.6 Million
Q2 2022

Aug 04, 2022

SELL
$120.42 - $169.29 $4.04 Million - $5.68 Million
-33,576 Reduced 17.98%
153,124 $22.3 Million
Q1 2022

May 05, 2022

SELL
$127.18 - $173.91 $119,676 - $163,649
-941 Reduced 0.5%
186,700 $30.5 Million
Q4 2021

Feb 02, 2022

BUY
$159.56 - $209.29 $1.07 Million - $1.41 Million
6,717 Added 3.71%
187,641 $31.8 Million
Q3 2021

Nov 02, 2021

SELL
$169.75 - $207.73 $542,521 - $663,905
-3,196 Reduced 1.74%
180,924 $34.2 Million
Q2 2021

Aug 02, 2021

SELL
$128.63 - $176.89 $42,962 - $59,081
-334 Reduced 0.18%
184,120 $31.2 Million
Q1 2021

May 11, 2021

SELL
$126.83 - $175.69 $1.79 Million - $2.48 Million
-14,100 Reduced 7.1%
184,454 $26 Million
Q4 2020

Feb 08, 2021

SELL
$122.97 - $147.0 $2.61 Million - $3.12 Million
-21,200 Reduced 9.65%
198,554 $25.8 Million
Q3 2020

Nov 05, 2020

SELL
$121.19 - $165.49 $2.76 Million - $3.77 Million
-22,795 Reduced 9.4%
219,754 $32 Million
Q2 2020

Aug 07, 2020

BUY
$104.21 - $156.44 $241,767 - $362,940
2,320 Added 0.97%
242,549 $35.9 Million
Q1 2020

May 06, 2020

SELL
$93.12 - $133.99 $1.22 Million - $1.75 Million
-13,091 Reduced 5.17%
240,229 $26.1 Million
Q4 2019

Feb 05, 2020

SELL
$74.51 - $124.23 $559,793 - $933,339
-7,513 Reduced 2.88%
253,320 $29.2 Million
Q3 2019

Nov 07, 2019

BUY
$70.9 - $87.82 $1.35 Million - $1.67 Million
19,071 Added 7.89%
260,833 $21 Million
Q2 2019

Aug 09, 2019

BUY
$65.86 - $92.79 $1.21 Million - $1.71 Million
18,399 Added 8.24%
241,762 $17.5 Million
Q1 2019

May 08, 2019

BUY
$72.76 - $93.45 $815,057 - $1.05 Million
11,202 Added 5.28%
223,363 $20.9 Million
Q4 2018

Feb 08, 2019

BUY
$62.67 - $88.33 $335,472 - $472,830
5,353 Added 2.59%
212,161 $15.5 Million
Q3 2018

Nov 07, 2018

BUY
$87.52 - $122.67 $334,939 - $469,458
3,827 Added 1.89%
206,808 $18.1 Million
Q2 2018

Aug 10, 2018

SELL
$88.31 - $107.8 $1.1 Million - $1.35 Million
-12,500 Reduced 5.8%
202,981 $20 Million
Q1 2018

May 10, 2018

SELL
$115.92 - $148.54 $185,472 - $237,664
-1,600 Reduced 0.74%
215,481 $25.7 Million
Q4 2017

Feb 13, 2018

BUY
$114.49 - $139.98 $67,892 - $83,008
593 Added 0.27%
217,081 $27.6 Million
Q3 2017

Nov 06, 2017

BUY
$72.53 - $118.27 $979,155 - $1.6 Million
13,500 Added 6.65%
216,488 $25.4 Million
Q2 2017

Aug 11, 2017

BUY
N/A
202,988
202,988 $16.2 Million

Others Institutions Holding ALNY

About ALNYLAM PHARMACEUTICALS, INC.


  • Ticker ALNY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 123,028,000
  • Market Cap $29.9B
  • Description
  • Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...
More about ALNY
Track This Portfolio

Track New York State Common Retirement Fund Portfolio

Follow New York State Common Retirement Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on New York State Common Retirement Fund with notifications on news.